Early research (Phase 1)WithdrawnNCT05614245
What this trial is testing
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant
Who this might be right for
COVID-19Coronavirus Infections
VBI Vaccines Inc.